Priming effect of homocysteine on inducible vascular cell adhesion molecule-1 expression in endothelial cells

Biomedicine and Pharmacotherapy

Volumn 62, Issue 6, 2008, Pages 395-400

  Séguin, Chantal ^a   Abid, Md Ruhul ^a   Spokes, Katherine C ^a   Schoots, Ivo G ^a   Brkovic, Alexandre ^b   Sirois, Martin G ^b   Aird, William C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Endothelium; Homocysteine; VCAM 1

Indexed keywords

HOMOCYSTEINE; LIPOPOLYSACCHARIDE; THROMBIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; INFLAMMATION; LEUKOCYTE ADHERENCE; MEDIATOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SENSITIZATION; VEIN THROMBOSIS;

EID: 46049094169     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.02.008     Document Type: Article

References (39)

1. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. Jama 274 13 (Oct 4 1995) 1049-1057
2. Den Heijer M., Lewington S., Clarke R., and Homocysteine. MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3 2 (Feb 2005) 292-299
3. Eberhardt R.T., Forgione M.A., Cap A., Leopold J.A., Rudd M.A., Trolliet M., et al. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 106 4 (Aug 2000) 483-491
4. Jiang X., Yang F., Tan H., Liao D., Bryan Jr. R.M., Randhawa J.K., et al. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 25 12 (Dec 2005) 2515-2521
5. Wang G., Woo C.W., Sung F.L., Siow Y.L., and O K. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol 22 11 (Nov 1 2002) 1777-1783
6. Li M., Chen J., Li Y.S., Feng Y.B., Gu X., and Shi C.Z. Folic acid reduces adhesion molecules VCAM-1 expression in aortic of rats with hyperhomocysteinemia. Int J Cardiol 106 2 (Jan 13 2006) 285-288
7. Au-Yeung K.K., Woo C.W., Sung F.L., Yip J.C., Siow Y.L., and O K. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ Res 94 1 (Jan 9 2004) 28-36
8. Poddar R., Sivasubramanian N., DiBello P.M., Robinson K., and Jacobsen D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103 22 (Jun 5 2001) 2717-2723
9. Koga T., Claycombe K., and Meydani M. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 161 2 (Apr 2002) 365-374
10. Meye C., Schumann J., Wagner A., and Gross P. Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells. Atherosclerosis 190 2 (Feb 2007) 256-263
11. Dudman N.P.B., Temple S.E., Guo X.W., Fu W., and Perry M.A. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 84 (1999) 409-416
12. Silverman M.D., Tumuluri R.J., Davis M., Lopez G., Rosenbaum J.T., and Lelkes P.I. Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 22 4 (Apr 1 2002) 587-592
13. Harrington E.O., Newton J., Morin N., and Rounds S. Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 287 6 (Dec 2004) L1091-L1097
14. Abid M.R., Tsai J.C., Spokes K.C., Deshpande S.S., Irani K., and Aird W.C. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. Faseb J 15 13 (2001) 2548-2550
15. Rollin S., Lemieux C., Maliba R., Favier J., Villeneuve L.R., Allen B.G., et al. VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis. Blood 103 10 (May 15 2004) 3789-3797
16. Wada Y., Otu H., Wu S., Abid M.R., Okada H., Libermann T., et al. Preconditioning of primary human endothelial cells with inflammatory mediators alters the "set point" of the cell. Faseb J 19 13 (Nov 2005) 1914-1916
17. Minami T., Abid M.R., Zhang J., King G., Kodama T., and Aird W.C. Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. J Biol Chem 278 9 (2003) 6976-6984
18. Minami T., and Aird W.C. Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-kappa B and GATA motifs. J Biol Chem 276 50 (2001) 47632-47641
19. Inoue K., Kobayashi M., Yano K., Miura M., Izumi A., Mataki C., et al. Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. Arterioscler Thromb Vasc Biol 26 12 (Dec 2006) 2652-2659
20. Minami T., Miura M., Aird W.C., and Kodama T. Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. J Biol Chem 281 29 (Jul 21 2006) 20503-20520
21. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107 10 (May 2001) 1255-1262
22. Nolte D., Kuebler W.M., Muller W.A., Wolff K.D., and Messmer K. Attenuation of leukocyte sequestration by selective blockade of PECAM-1 or VCAM-1 in murine endotoxemia. Eur Surg Res 36 6 (Nov-Dec 2004) 331-337
23. Yano K., Liaw P.C., Mullington J.M., Shih S.C., Okada H., Bodyak N., et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 203 6 (Jun 12 2006) 1447-1458
24. Reinhardt P.H., Elliott J.F., and Kubes P. Neutrophils can adhere via alpha4beta1-integrin under flow conditions. Blood 89 10 (May 15 1997) 3837-3846
25. Ibbotson G.C., Doig C., Kaur J., Gill V., Ostrovsky L., Fairhead T., et al. Functional alpha4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients. Nat Med 7 4 (Apr 2001) 465-470
26. Taooka Y., Chen J., Yednock T., and Sheppard D. The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol 145 2 (Apr 19 1999) 413-420
27. Abdala-Valencia H., and Cook-Mills J.M. VCAM-1 signals activate endothelial cell protein kinase Calpha via oxidation. J Immunol 177 9 (Nov 1 2006) 6379-6387
28. Minami T., Abid M.R., Zhang J., King G., Kodama T., and Aird W.C. Thrombin stimulation of VCAM-1 in endothelial cells is mediated by PKC-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. J Biol Chem 18 (2002) 18
29. Rahman A., Anwar K.N., True A.L., and Malik A.B. Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J Immunol 162 9 (1999) 5466-5476
30. Min J.K., Kim Y.M., Kim S.W., Kwon M.C., Kong Y.Y., Hwang I.K., et al. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells. J Immunol 175 1 (Jul 1 2005) 531-540
31. Carluccio M.A., Ancora M.A., Massaro M., Carluccio M., Scoditti E., Distante A., et al. Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol Heart Circ Physiol 293 4 (Oct 2007) H2344-H2354
32. Jakubowski H. The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin Chem Lab Med 45 12 (2007) 1704-1716
33. Jakubowski H. Translational accuracy of aminoacyl-tRNA synthetases: implications for atherosclerosis. J Nutr 131 (2001) S2983-S2987
34. Jakubowski H., Zhang L., Bardeguez A., and Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res 87 (2000) 45-51
35. Jakubowski H. Pathophysiological consequences of homocysteine excess 1. J Nutr 136 (2006) 1741S-1749S
36. Harker L.A., Ross R., Slichter S.J., and Scott C.R. Homocysteine-induced atherosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58 (1976) 731-741
37. Rodgers G.M., and Kane W.H. Activation of endogenous Factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77 (1986) 1909-1916
38. Undas A., Perla J., Lacinski M., Trzeciak W., Kazmierski R., and Jakubowski H. Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke 35 (2004) 1299-1304
39. Sauls D.L., Lockhart E., Warren M.E., Lenkowski A., Wilhelm S.E., and Hoffman M. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry 45 (2006) 2480-2487